Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,148
Closed -$7.16M 1152
2022
Q4
$7.66M Buy
29,148
+17,251
+145% +$4.62M 0.78% 23
2022
Q3
$2.68M Sell
11,897
-6,052
-34% -$1.47M 0.18% 124
2022
Q2
$4.37M Sell
17,949
-2,319
-11% -$568K 0.22% 92
2022
Q1
$4.9M Buy
20,268
+5,662
+39% +$1.3M 0.21% 84
2021
Q4
$3.29M Buy
+14,606
New +$3.08M 0.09% 198
2014
Q3
Sell
-59,574
Closed -$7.05M 994
2014
Q2
$7.05M Buy
59,574
+47,488
+393% +$5.5M 0.26% 80
2014
Q1
$1.49M Buy
+12,086
New +$1.47M 0.07% 253

Other funds holding AMGN

HAP Trading's AMGN Position: Q1 2023 in Review

HAP Trading sold out of Amgen (AMGN) in Q1 2023, closing a stake of 29,148 shares — an estimated $7.16M sold.

HAP Trading first reported a position in AMGN in Q1 2014 and held it in 7 quarters. The position peaked at $7.66M in Q4 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • HAP Trading reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 29,148 Amgen shares in Q1 2023, an estimated $7.16M.
  • HAP Trading first reported a position in Amgen in Q1 2014 and held it in 7 quarters.
  • HAP Trading's Amgen position peaked at $7.66M in Q4 2022.
  • 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.